Analysis ·
Nvidia invests in Doctolib: looking back at a French success story
Original title, in French: “Nvidia investit dans DOCTOLIB : retour sur une success story française”
- Publication
- FrenchWeb (France)
- Author
- Unsigned
- Published on
- 14 October 2026 · read in the page structured data
Summary
The article traces thirteen years of Doctolib funding, up to Nvidia's recent investment, announced by Jensen Huang in Paris on 13 October 2026. Doctolib claims 520,000 healthcare professionals and 90 million patients across five countries, and reports annualised recurring revenue of €422 million in 2025. Nvidia's investment, a minority stake without a board seat, is intended to accelerate the development of AI models, assistants for healthcare professionals and a "health companion" for patients, built on open models with data hosted in Europe. Doctolib is thus positioning itself against vendors such as Cegedim and CompuGroup Medical, while the company remains subject to a €4.665 million fine from the French competition authority (Autorité de la concurrence) and faces sovereignty questions linked to the presence of US shareholders.
Summary based on the full text of the article.
Read the article on FrenchWeb →Figures cited
-
520,000 professionals
Number of healthcare professionals claimed by Doctolib
Doctolib, 2026, five European countries
« la société française revendique 520 000 professionnels de santé et 90 millions de patients dans cinq pays européens »
Source: Doctolib
-
90,000,000 patients
Number of patients claimed by Doctolib
Doctolib, 2026, five European countries
« la société française revendique 520 000 professionnels de santé et 90 millions de patients dans cinq pays européens »
Source: Doctolib
-
422 M€
Doctolib's annualised recurring revenue in 2025
Doctolib, 2025 financial year
« Doctolib communique un revenu récurrent annualisé de 348 millions d’euros en 2024, puis de 422 millions en 2025 »
Source: Doctolib
-
348 M€
Doctolib's annualised recurring revenue in 2024
Doctolib, 2024 financial year
« Doctolib communique un revenu récurrent annualisé de 348 millions d’euros en 2024, puis de 422 millions en 2025 »
Source: Doctolib
-
3.6 €bn
Doctolib's implied valuation in the spring 2026 secondary transaction
Doctolib, spring 2026, secondary transaction on existing shares
« La valorisation implicite ressort à 3,6 milliards d’euros, soit environ 38 % sous celle de 2022. »
Source: TICsanté
-
4.665 M€
Fine imposed on Doctolib by the Autorité de la concurrence
France, November 2025
« l’Autorité de la concurrence a sanctionné Doctolib à hauteur de 4,665 millions d’euros pour des pratiques d’exclusivité, des ventes liées et l’acquisition de MonDocteur »
Source: Autorité de la concurrence
Classification
- Country
- France, Germany, Italy, Netherlands, United Kingdom
- Company size
- All sizes
- Industries
- Healthcare, pharmaceuticals, social care · Software vendors, IT services companies, telecoms
- Companies
- Eurazeo (cited), Cegedim (cited), Doctolib (deploys AI), General Atlantic (cited), Accel (cited), Bpifrance (cited), CompuGroup Medical (cited), Nvidia (supplier)
- Keywords
- digital health, AI assistants, open models, data sovereignty, funding, doctolib
Entry written by Marsanne Studio from the cited article, with the help of an AI model (claude-sonnet-5). The rights to the article and its illustrations belong to FrenchWeb. Entry translated from French by Claude Sonnet 5.5.